ArticleFrontiers in oncology2017

Targeting Ongoing DNA Damage in Multiple Myeloma: Effects of DNA Damage Response Inhibitors on Plasma Cell Survival.

Ana Belén Herrero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.